Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
Datroway's approval is based on results from the Phase III TROPION-Breast01 trial.
Syngene Thematic ADC WP
FDA awards breakthrough therapy status to BMS and SystImmune’s NSCLC drug
GSK’s Blenrep faces setback as FDA cancer committee votes against approval
GSK’s Blenrep US comeback hindered by eye safety concerns
Piramal Pharma announces $90m investment to expand US sites
FDA approves AstraZeneca and Daiichi Sankyo’s Datroway for NSCLC
Orion and Glykos extend ADC collaboration
NextCure and Simcere partner to develop SIM0505 for solid tumours
